Delay in starting radiotherapy due to neoadjuvant therapy does not worsen survival in unresected glioblastoma patients

Carmen Balana,Anna Estival,Iris Teruel,Max Hardy-Werbin,Juan Manuel Sepúlveda,Estela Pineda,M. Martinez-Garcia,Oscar Gallego,R Luque,Miguel Gil-Gil,Carlos Mesia,S. Del Barco,Ana Herrero,Alfonso Berrocal,P. Perez Segura,R. de las Peñas,J. Marruecos,R. Fuentes,Gaspar Reynés,J.M. Velarde,Andrés F. Cardona,E. Verger,C. Panciroli,S. Villa

Delay in starting radiotherapy due to neoadjuvant therapy does not worsen survival in unresected glioblastoma patients

2018

Purpose We retrospectively examined the potential effect on overall survival (OS) of delaying radiotherapy to administer neoadjuvant therapy in unresected glioblastoma patients.

Keywords:

Radiology
General surgery
Glioblastoma
Unresected
Neoadjuvant therapy
Radiation therapy
Medicine
potential effect
Internal medicine
Oncology
overall survival

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations